icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Paris France
11-15 April 2018
Back grey_arrow_rt.gif
 
 
 
Combination of an FXR Agonist and an ACC Inhibitor Increases Antifibrotic Efficacy in Rodent Models of NASH
 
 
  Reported by Jules Levin
EASL 2018 April 11-15 Paris France
 
Jamie Bates, Kathy Liu, David Hollenback, Anna Zagorska, Grant Budas, John T. Liles, Henry Liu, Saritha Kusam, Robert Brockett, David Newstrom, Igor Mikaelian, Ting Wang, Adrian S. Ray, David G. Breckenridge
Gilead Sciences, Inc., Foster City, California, USA

0515181

0515182

0515183

0515184

0515185

0515186

0515187

0515188

0515189

05151810

References
 
1. Hambruch E, et al. Nucl Receptor Res 2016;3; 2. Abu-Elheiga L, et al. Proc Natl Acad Sci USA 2005;102:12011-6; 3. Mao J, et al. Proc Natl Acad Sci USA 2006;103:8552-7; 4. Harriman G, et al. Proc Natl Acad Sci USA 2016;113:E1796-805; 5. Lawitz EJ, et al. EASL 2017, abstr LBO-002; 6. Loomba R, et al. AASLD 2017, abstr LB-9; 7. Charlton M, et al. Am J Physiol Gastrointest Liver Physiol 2011;301:G825-34.